I guess it was different when they were doing the same thing to your mob in the 90 cent range ? I think you have your own "shorter' problems to worry about - just sayin'
Many keep forgetting that the FDA's guidance for Rex-L that is due in the near future (if you work off their own scheduled timelines of 60 days) will either be -
1. Go away and do another 3 year trial; or
2. We recommend you make an application through the AA program for high-risk HFrEF patients with diabetes and/or myocardial ischemia.
With the positive results from the DREAM-HF trial there will be a partnership for either path chosen IMO and it will already be sitting in the wings waiting with a "what if the FDA chooses a new trial ?" or a "what if the FDA recommends an AA application ?" scenario ....
.... Mesoblast have had ample time to arrange the scenario outlined above IMO and I cannot see them announcing the FDA's guidance without it being in conjunction with the corresponding partnership announcement ? I have been wrong before so I wouldn't rush out and buy shares on my opinion though ... let's see what happens ?
In the meantime, ponder over the previous CHF partnerships deal remembering that it was finalised without the current phase 3 trial results / data Mesoblast have and if the FDA give the nod for an AA application for a reduced cohort with a confirmatory trial, then IMO the new deal would dwarf this one in comparison
https://www.genengnews.com/topics/t...s $130 million up,19.99% stake in Aussie firm.
Cephalon Shells Out $350M to Commercialize Mesoblast Stem Cell Therapies
Cephalon is paying Mesoblast $130 million up front and will make a $220 million equity investment in the Australian firm as part of a collaboration to develop and commercialize adult mesenchymal precursor stem cell (MPC) therapies based on Mesoblast’s adult stem cell technology platform.
- Forums
- ASX - By Stock
- MSB
- Ann: MSB Q3 Financial Results and Operational Highlights
Ann: MSB Q3 Financial Results and Operational Highlights, page-131
-
- There are more pages in this discussion • 47 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add MSB (ASX) to my watchlist
|
|||||
Last
96.0¢ |
Change
0.025(2.67%) |
Mkt cap ! $1.096B |
Open | High | Low | Value | Volume |
95.0¢ | 96.5¢ | 94.0¢ | $1.231M | 1.291M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
4 | 94461 | 95.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
96.0¢ | 61151 | 6 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
4 | 94461 | 0.950 |
6 | 59977 | 0.945 |
9 | 154571 | 0.940 |
4 | 44875 | 0.935 |
5 | 92633 | 0.930 |
Price($) | Vol. | No. |
---|---|---|
0.960 | 61151 | 6 |
0.965 | 46785 | 5 |
0.970 | 48228 | 6 |
0.975 | 64461 | 2 |
0.980 | 31269 | 3 |
Last trade - 16.10pm 12/09/2024 (20 minute delay) ? |
Featured News
MSB (ASX) Chart |